181 related articles for article (PubMed ID: 9035202)
1. The Hirschsprung's-multiple endocrine neoplasia connection.
Moore SW; Zaahl M
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):63-7. PubMed ID: 22584708
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism.
Cosma MP; Cardone M; Carlomagno F; Colantuoni V
Mol Cell Biol; 1998 Jun; 18(6):3321-9. PubMed ID: 9584172
[TBL] [Abstract][Full Text] [Related]
3. The RET proto-oncogene: a molecular therapeutic target in thyroid cancer.
Kodama Y; Asai N; Kawai K; Jijiwa M; Murakumo Y; Ichihara M; Takahashi M
Cancer Sci; 2005 Mar; 96(3):143-8. PubMed ID: 15771616
[TBL] [Abstract][Full Text] [Related]
4. Non-syndromic Hirschsprung's disease as a result of a RETÂ gene variant.
Gietz R; Armando R; Lobos P; Liberto D
Cir Pediatr; 2024 Apr; 37(2):89-92. PubMed ID: 38623803
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of clinical outcome in patients with total intestinal aganglionosis.
Ruttenstock E; Puri P
Pediatr Surg Int; 2009 Oct; 25(10):833-9. PubMed ID: 19669647
[TBL] [Abstract][Full Text] [Related]
6. RET/GDNF signalling in vagal neural crest-derived neurons of the chick embryo cloaca.
O' Donnell AM; Puri P
Pediatr Surg Int; 2008 Nov; 24(11):1211-4. PubMed ID: 18726603
[TBL] [Abstract][Full Text] [Related]
7. Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients.
Sangkhathat S; Kusafuka T; Chengkriwate P; Patrapinyokul S; Sangthong B; Fukuzawa M
J Hum Genet; 2006; 51(12):1126-1132. PubMed ID: 17009072
[TBL] [Abstract][Full Text] [Related]
8. Enteric nervous system and developmental abnormalities in childhood.
Paran TS; Rolle U; Puri P
Pediatr Surg Int; 2006 Dec; 22(12):945-59. PubMed ID: 17001489
[TBL] [Abstract][Full Text] [Related]
9. Putting the bits and pieces of the RET proto-oncogene puzzle together.
Gagel RF
Bone; 1995 Aug; 17(2 Suppl):13S-16S. PubMed ID: 8579892
[TBL] [Abstract][Full Text] [Related]
10. The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.
Kusafuka T; Puri P
Pediatr Surg Int; 1997; 12(1):11-8. PubMed ID: 9035202
[TBL] [Abstract][Full Text] [Related]
11. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
[TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].
Hofstra RM; van der Luijt RB; Lips CJ
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2217-21. PubMed ID: 11757244
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
Eng C; Mulligan LM
Hum Mutat; 1997; 9(2):97-109. PubMed ID: 9067749
[TBL] [Abstract][Full Text] [Related]
14. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
